Artificial Intelligence for Early Sepsis Recognition and Timely Antibiotic Administration across Emergency and Critical Care Settings: A Systematic Review of Diagnostic Performance and Clinical Outcomes
Journal of Pioneering Medical Sciences · 2026-11-05 · 15 (10) · 199-205
DOI: 10.47310/jpms2026151020 ↗Abstract
Background: Sepsis remains a leading cause of morbidity and mortality, where early recognition and timely antibiotic administration are critical. Artificial Intelligence (AI) has been increasingly investigated for sepsis prediction and clinical decision support across emergency and critical care settings. Objective: To systematically evaluate the diagnostic performance of AI models for early sepsis recognition and their reported effects on time-to-antibiotic administration and selected clinical outcomes. Methods: Following PRISMA 2020 guidelines, we searched PubMed, Scopus, Web of Science, Embase and Google Scholar from 2015 to January 2026. Studies evaluating AI-based models for sepsis detection that reported diagnostic accuracy, time-to-antibiotics, mortality, or length of stay were included. Two reviewers independently screened and extracted data. Results: Ten studies were included (randomized trials, prospective and retrospective cohorts and before-and-after studies) conducted in emergency departments, intensive care units, hospital wards and prehospital settings. AI models showed AUROC values ranging from 0.83 to 0.92 across different validation approaches. Several implementation studies reported reductions in time-to-antibiotic administration (absolute differences ranging from approximately 10-16 minutes, or higher proportions of patients receiving antibiotics within 1-3 hours). Effects on mortality and length of stay were inconsistent across studies. Conclusion: AI-based systems demonstrate promising diagnostic performance for early sepsis recognition and, in selected implementation studies, appear to accelerate antibiotic administration. However, substantial heterogeneity in study designs, settings, sepsis definitions and outcome measures limits the ability to draw firm conclusions about consistent clinical effectiveness. Further prospective validation and implementation research are needed.
EUVIMED